Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu W- min, d’Amore ESG, Li Y, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Wang H-Y, Dunphy CH, His ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Ai W, O’Neill S, Ponzoni M, Ferreri AJ, Kahl BS, Winter JN, Go RS, Dirnhofer S, Piris MA, Møller MB, Wu L, Medeiros LJ, Young KH. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica [Internet]. 2013Jan.31 [cited 2026Nov.5];98(2):255-63. Available from: https://haematologica.org/article/view/6562